This is Sabin’s second Phase 2 clinical trial partnership with MUWRP, based in Uganda’s capital, Kampala. A Phase 2 trial for a Marburg vaccine is already underway, having recently completed ...

(NASDAQ:MDAI) and assign a valuation of $5.00 per share. This valuation is based on our estimates for sale of the DeepView system to evaluate burn injury and to assist in diagnosis and triage.

A raw milk dairy farmer and longtime critic of the FDA has accused officials of ignoring his tip about a possible H5N1 ...

The Biomedical Advanced Research and Development Authority (BARDA) has awarded a $749,999 contract to Cambridge, ...

Cytovale Inc. and the Biomedical Advanced Research and Development Authority, or BARDA, announced cooperation in April 2020 ...

Contract research organization Allucent has been chosen as a partner for the U.S. Biomedical Advanced Research and ...

The Emeryville, California, company announced last September that it was awarded a $433 million contract with the Biomedical ...

The U.S. Department of Health and Human Services is awarding Moderna $176 million to develop a human vaccine for H5N1 avian influenza. Funding will be allocated through the Biomedical Advanced ...

With the motive of being better prepared for future pandemics, the U.S. Department of Health and Human Services (HHS) has ...

While there have not been any confirmed human cases of bird flu transmission as a result of raw milk consumption, health ...

Health officials have not provided the exact date when the person was first diagnosed nor if there was any genetic testing of ...